×
App Icon
The Standard e-Paper
Home To Bold Columnists
★★★★ - on Play Store
Download Now

FDA warns about counterfeit versions of diabetes drug Ozempic

Vocalize Pre-Player Loader

Audio By Vocalize

A pharmacist displays boxes of Ozempic, a drug used for treating type 2 diabetes and obesity made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, on March 29, 2023. [Reuters]

The U.S. Food and Drug Administration on Thursday warned consumers not to use counterfeit versions of Novo Nordisk's diabetes drug Ozempic that have been found in the country's drug supply chain.

The health regulator said that it would continue to investigate counterfeit Ozempic 1-milligram injections and had seized thousands of units, but that some might still be available for purchase.

Get Full Access for Ksh299/Week.
Uncover the stories others won’t tell. Subscribe now for exclusive access
  • Unlimited access to all premium content
  • Uninterrupted ad-free browsing experience
  • Mobile-optimized reading experience
  • Weekly Newsletters
  • MPesa, Airtel Money and Cards accepted
Already a subscriber? Log in
Football
Title-hungry Leopards seek to bounce back to winning ways
Golf
Magical Kenya Open: Jastas Madoya reveals what fuels his passion for golf
Olympics
NOC-K signs strategic MoU with Japanese Olympic Committee
Unique Sports
Youthful Kinoti Kiara crowned African fencing champion